Hepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C

Journal of Viral Hepatitis

Volumn 22, Issue 2, 2015, Pages 144-155

  Bostjancic E ^a   Bandelj, E ^a   Luzar, B ^a   Poljak, M ^a   Glavac D ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

hepatic expression; hepatitis C; microRNAs; pathohistology and clinics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; MICRORNA; MICRORNA 122; MICRORNA 126; MICRORNA 136; MICRORNA 181A; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENETIC ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 1A; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 4; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; VIRUS LOAD; VIRUS TRANSMISSION; BIOPSY; BIOSYNTHESIS; CLASSIFICATION; CYTOCHEMISTRY; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HEPACIVIRUS; ISOLATION AND PURIFICATION; LIVER; MIDDLE AGED; PATHOLOGY; SERUM; VIROLOGY; YOUNG ADULT;

ADULT; AGED; BIOPSY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HISTOCYTOCHEMISTRY; HUMANS; LIVER; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SERUM; YOUNG ADULT;

EID: 84921437417     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12266     Document Type: Article

References (56)

1. Georgel P, Schuster C, Zeisel MB, et al,. Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. Trends Mol Med 2010; 16: 277-286.
2. Asselah T, Bièche I, Sabbagh A, et al,. Gene expression and hepatitis C virus infection. Gut 2009; 58: 846-858.
3. Fabris P, Fleming VM, Giordani MT, Barnes E,. Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection. Curr Pharm Des 2008; 14: 1661-1665.
4. Myrmel H, Ulvestad E, Asjø B,. The hepatitis C virus enigma. APMIS 2009; 117: 427-439.
5. Simmonds P, Bukh J, Combet C, et al,. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-973.
6. Chen XM,. MicroRNA signatures in liver diseases. World J Gastroenterol 2009; 15: 1665-1672.
7. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-1581.
8. Thibault PA, Huys A, Dhillon P, Wilson JA,. MicroRNA-122-dependent and -independent replication of Hepatitis C Virus in Hep3B human hepatoma cells. Virology 2013; 436: 179-190.
9. Li YP, Gottwein JM, Scheel TK, Jensen TB, Bukh J,. MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR. Proc Natl Acad Sci U S A 2011; 108: 4991-4996.
10. Hoffmann TW, Duverlie G, Bengrine A,. MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy. Virol J 2012; 9: 109.
11. Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K,. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol 2009; 50: 453-460.
12. Cheng JC, Yeh YJ, Tseng CP, et al,. Let-7b is a novel regulator of hepatitis C virus replication. Cell Mol Life Sci 2012; 69: 2621-2633.
13. Morita K, Taketomi A, Shirabe K, et al,. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int 2011; 31: 474-484.
14. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D,. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-122.
15. Goodman ZD,. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 2007; 47: 598-607.
16. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293.
17. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
18. Krek A, Grün D, Poy MN, et al,. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500.
19. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB,. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.
20. Wang X,. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008; 14: 1012-1017.
21. Huang DW, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
22. Sethupathy P, Corda B, Hatzigeorgiou AG,. TarBase: a comprehensive database of experimentally supported animal microRNA targets. RNA 2006; 12: 192-197.
23. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ,. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140-D144.
24. Chiromatzo AO, Oliveira TY, Pereira G, et al,. miRNApath: a database of miRNAs, target genes and metabolic pathways. Genet Mol Res 2007; 6: 859-865.
25. Lu M, Shi B, Wang J, Cao Q, Cui Q,. TAM: a method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC Bioinformatics 2010; 11: 419.
26. Lu M, Zhang Q, Deng M, et al,. An analysis of human microRNA and disease associations. PLoSONE 2008; 3: e3420.
27. Nasta P,. 'Immune activation, aging and gender' and progression of liver disease. Acta Biomed 2011; 82: 115-123.
28. Li G, Yu M, Lee WW, et al,. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med 2012; 18: 1518-1524.
29. Marquez RT, Bandyopadhyay S, Wendlandt EB, et al,. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest 2010; 90: 1727-1736.
30. Delic D, Grosser C, Dkhil M, Al-Quraishy S, Wunderlich F,. Testosterone-induced upregulation of miRNAs in the female mouse liver. Steroids 2010; 75: 998-1004.
31. Sanyal AJ,. Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C. Liver Int 2011; 31 (Suppl 1): 23-28.
32. Munagala R, Aqil F, Vadhanam MV, Gupta RC,. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention. Cancer Lett 2013; 339: 175-184.
33. Cohen A, Smith Y,. Estrogen Regulation of MicroRNAs, Target Genes, and MicroRNA Expression Associated with Vitellogenesis in the Zebrafish. Zebrafish 2013. doi: 10.1089/zeb.2013.0873.
34. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W,. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009; 15: 31-33.
35. Moore KJ, Rayner KJ, Suárez Y, Fernández-Hernando C,. microRNAs and cholesterol metabolism. Trends Endocrinol Metab 2010; 21: 699-706.
36. Her GM, Hsu CC, Hong JR, et al,. Overexpression of gankyrin induces liver steatosis in zebrafish (Danio rerio). Biochim Biophys Acta 2011; 1811: 536-548.
37. Rice CM,. New insights into HCV replication: potential antiviral targets. Top Antivir Med 2011; 19: 117-120.
38. Lee DY, Jeyapalan Z, Fang L, et al,. Expression of versican 3'-untranslated region modulates endogenous microRNA functions. PLoS ONE 2010; 5: e13599.
39. Yang Y, Wu J, Guan H, et al,. MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. FEBS Lett 2012; 586: 3608-3612.
40. Clément S, Peyrou M, Sanchez-Pareja A, et al,. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets. Hepatology 2011; 54: 38-49.
41. Walsh MJ, Vanags DM, Clouston AD, et al,. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 2004; 39: 1230-1238.
42. Ferlan-Marolt V,. Patohistological features of chronic viral hepatitis as a diagnostic challenge. In:, Luzar B, Vizjak A, Volavšek M, Popovic M, Franchi A, eds. News in Pathology: Celebrating 70th Anniversary of the Institute of Pathology, Faculty of Medicine, University of Ljubljana. Ljubljana: Institute of pathology, Faculty of medicine, 2010: 197-200.
43. Bala S, Marcos M, Szabo G,. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009; 15: 5633-5640.
44. Urbich C, Kuehbacher A, Dimmeler S,. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008; 79: 581-588.
45. Sheedy FJ, O'Neill LA,. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008; 67 (Suppl 3): iii50-iii55.
46. Liu X, Wang T, Wakita T, Yang W,. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 2010; 398: 57-67.
47. Meister J, Schmidt MH,. miR-126 and miR-126: new players in cancer. Sci World J 2010; 10: 2090-2100.
48. Negro F,. Steatosis and insulin resistance in response to treatment of chronic hepatitis C. J Viral Hepat 2012; 19 (Suppl 1): 42-47.
49. Jiang X, Tsitsiou E, Herrick SE, Lindsay MA,. MicroRNAs and the regulation of fibrosis. FEBS J 2010; 277: 2015-2021.
50. Trebicka J, Anadol E, Elfimova N, et al,. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J Hepatol 2013; 58: 234-239.
51. Mormone E, George J, Nieto N,. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact 2011; 193: 225-231.
52. Tsamandas AC, Thomopoulos K, Gogos C, et al,. Expression of bcl-2 oncoprotein in cases of acute and chronic viral hepatitis type B and type C: a clinicopathologic study. Dig Dis Sci 2002; 47: 1618-1624.
53. Tsamandas AC, Thomopoulos K, Zolota V, et al,. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Mod Pathol 2003; 16: 1273-1288.
54. Piekarska A, Kubiak R, Omulecka A, Szymczak W, Piekarski J,. Expression of Bax, Bcl-xL and Bcl-2 proteins in relation to grade of inflammation and stage offibrosis in chronic hepatitis C. Histopathology 2007; 50: 928-935.
55. Ramalho F, Costa A, Pires A, et al,. Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C. Dig Dis Sci 2000; 45: 182-187.
56. van der Meer AJ, Farid WR, Sonneveld MJ, et al,. Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122. J Viral Hepat 2013; 20: 158-166.